Geoff Hamilton is the Chief Business and Chief Financial Officer of Ansa Biotechnologies, a leading provider of gene synthesis products powering the next era of medicines and engineered biology. Geoff has a 24 year career in the industry spanning life science tools, genomics, and therapeutics. Geoff has been a leader in developing and launching revolutionary technologies in next-generation sequencing and applying gene and cell engineering tools to develop breakthrough therapeutics. Prior to joining Ansa, Geoff was the cofounder and CEO of Stemson Therapeutics, a cell therapy company developing regenerative treatments for skin diseases and hair loss conditions. Prior to founding Stemson, he spent six years at Illumina where he held leadership positions in product commercialization, clinical marketing, sequencing application strategy, and product portfolio management. Before Illumina, Geoff spent a decade at Life Technologies, a leading provider of tools, reagents, and analytical instruments before it was acquired by ThermoFisher Scientific. At Life Tech, he held a number of finance, marketing, commercial, and acquisition leadership roles.